Navigation Links
BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture
Date:1/3/2008

ming of decisions by regulatory authorities concerning marketing applications, labeling and pricing for Aldurazyme and manufacturing facilities to be used for Aldurazyme; the companies' ability to obtain and maintain adequate patent and other proprietary rights protection for Aldurazyme; and those factors detailed in BioMarin's and Genzyme's filings with the Securities and Exchange Commission, including, without limitation, the factors contained under the caption "Risk Factors" in BioMarin's 2006 Annual Report on Form 10-K, as amended, the factors contained in BioMarin's reports on Form 8-K, and the factors discussed under the caption "Risk Factors" in Genzyme's Quarterly Report on Form 10-Q for the quarter ended September 30, 2007. Stockholders are urged not to place undue reliance on forward-looking statements, which speak only as of the date hereof. Neither BioMarin nor Genzyme is under any obligation, and expressly disclaims any obligation to update or alter any forward-looking statement, whether as a result of new information, future events or otherwise.

BioMarin(R) is a registered trademark of BioMarin Pharmaceutical Inc.

Genzyme(R) is a registered trademark of Genzyme Corporation.

Aldurazyme(R) is a registered trademark of BioMarin/Genzyme LLC.

All rights reserved.

Contact:

BioMarin Genzyme

Investors Investors

Eugenia Shen Sally Curley

(415) 506-6570 (617) 768-6140

Media Media

Susan Berg Maria Cantor

(415) 506-6594 (617) 768-6690


'/>"/>
SOURCE BioMarin Pharmaceutical Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. BioMarin and IGAN Biosciences to Collaborate on Development of an Enzyme Therapy to Treat IgA Nephropathy, a Rare and Life-Threatening Kidney Disease
2. BioMarin to Present at the Rodman & Renshaw 9th Annual Healthcare Conference
3. BioMarin to Present at the BioCentury NewsMakers Conference
4. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
5. Genzyme Receives European CE Mark for Single-Treatment Synvisc-One(TM)
6. Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation
7. Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
8. Genzyme and Sunway to Collaborate on Gene Therapy Program in China
9. BioVex Appoints Genzyme Executive, Jan van Heek, as Chairman of the Board of Directors
10. Genzyme Launches Cholestagel(R) in Europe
11. FDA Approves Genzymes Renvela(TM) for Dialysis Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)... CHENGDU, China, Dec. 2 /PRNewswire-Asia-FirstCall...oNext: TPI), a manufacturer and supplier,of moder...n Chengdu, China,today announced the implementat...gorize both distributors and hospital clients into...nd marketing structure. , The new strategy ...
(Date:12/2/2008)... HillmanCancerCenter Joins Trial with James Pingpa... NEW YORK, Dec. 2 Delca...y that the Hillman Cancer Center of the Universit... Delcath,s Phase III clinical trial testing its Pe...inoperable metastatic melanoma in the liver. Jame...
(Date:12/2/2008)... TIRAT CARMEL, Israel, December 2 /PRNewswire/...cations show that Magnetic Resonance-guided Focuse... has the potential to be an,effective noninvasive...ead to,the bones (bone metastases). The results o...line issue of Annals of Surgical Oncology, while d...
(Date:12/2/2008)... PALO ALTO, Calif., Dec. 2 Intradi...systemic RNA interference (RNAi) therapeutics, tod... 7,459,547, entitled "Methods,and Compositions fo...ued,patent, which is based on the seminal researc...k Chair of Biomedical Sciences and Professor of Bi...
Breaking Biology Technology:Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth 2Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth 3Delcath Adds University of Pittsburgh Medical Center to Phase III Trial 2Delcath Adds University of Pittsburgh Medical Center to Phase III Trial 3Delcath Adds University of Pittsburgh Medical Center to Phase III Trial 4New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases 2New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases 3New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases 4Intradigm Announces Issuance of Key Patent Related to Enhancing Efficacy and Potency of RNAi Therapeutics 2Intradigm Announces Issuance of Key Patent Related to Enhancing Efficacy and Potency of RNAi Therapeutics 3
...Wisconsin Department of Workforce Development wil...a partnership that promotes high-tech skills train...or the Future Initiative, will support the Emergin...ct builds partnerships between businesses and scho... for the high-tech job market. , ,Grants will be o...
...bill to provide $4 billion in competitive grants i...formation technology and services. , ,The bill, in...nd Olympia Snowe , R-Maine, is called the Health ...rcent of the grant money will be available to heal...affordability of information technology is an issu...
...rday from a week,s trip to Sao Paulo, Brazil, wher...anagement-Latin America course, a group of executi...r, Abbott, Hospira, Grainger, Motorola, AT&T) to t...e huge megapolis! Having recently returned from wh... world, Delhi (15.0 million people) and Mumbai (18...
...g more women-owned businesses to the $1 million an...ces and tools, perhaps none more important than in...ges to come out of the recent Wisconsin Make Mine...were encouraged to leverage information technology...1 million mark. , ,The advice they absorbed from t...
Other Biology Technology:Brazilian bio-industry should impress American investors 2Brazilian bio-industry should impress American investors 3Brazilian bio-industry should impress American investors 4Brazilian bio-industry should impress American investors 5Brazilian bio-industry should impress American investors 6Learning from the big boys: With technology, women urged to go gradual 2Learning from the big boys: With technology, women urged to go gradual 3
(Date:12/2/2008)... Purdue University have developed a technique that...numerous tiny particles within seconds, representi...les or create devices using nanoassembly. , The ... is a potential alternative to existing technologi...sily changed, said mechanical engineering doctoral...
(Date:12/2/2008)...ted States that are at the highest risk of sustain...ough to the dangers posed by rising temperatures, ...ntury of climate change that has already significa...ns and has already had widespread ecological and h...that the United States will experience at least as...
(Date:12/2/2008)...ungsgemeinschaft (DFG, German Research Foundation)...s. They will be initially funded for the next four...ros. Among other things, the new Collaborative Res...aused by viruses and bacteria, scarring of the liv...nclude the optimisation of planning, production an...
(Date:12/2/2008)... ,, Where would we be without our ability ...ter, to forget irrelevant details? Thanks to the f..., called synapses, we are good at both. Up to now,... to play an active role in this reorganization of ...y to learn but also to forget. An incorrect assump...
Breaking Biology News(10 mins):New holographic method could be used for lab-on-a-chip technologies 2New holographic method could be used for lab-on-a-chip technologies 3New holographic method could be used for lab-on-a-chip technologies 4Most US organizations not adapting to climate change 2Most US organizations not adapting to climate change 3From sheet metal elements to host cells: DFG launches 10 new collaborative research centers 2From sheet metal elements to host cells: DFG launches 10 new collaborative research centers 3From sheet metal elements to host cells: DFG launches 10 new collaborative research centers 4From sheet metal elements to host cells: DFG launches 10 new collaborative research centers 5From sheet metal elements to host cells: DFG launches 10 new collaborative research centers 6From sheet metal elements to host cells: DFG launches 10 new collaborative research centers 7It takes 2 to tango 2It takes 2 to tango 3Worlds Miracle Baby Turns One 4434 1Coping with the Stress of Natural Disasters 4432 1Coping with the Stress of Natural Disasters 4432 2Draft Rules Wont Stop Insurers Illegal Cancellations of Health Policies 4430 1Draft Rules Wont Stop Insurers Illegal Cancellations of Health Policies 4430 2Draft Rules Wont Stop Insurers Illegal Cancellations of Health Policies 4430 3Franklin 26 Seidelmann Enters Full Service Teleradiology Market with Acquisition of Apex Radiology 4428 1Franklin 26 Seidelmann Enters Full Service Teleradiology Market with Acquisition of Apex Radiology 4428 2Franklin 26 Seidelmann Enters Full Service Teleradiology Market with Acquisition of Apex Radiology 4428 3
...ohns Hopkins have discovered how taking the brakes... in a common form of lung cancer. , Products made... environmental pollutants like cigarette smoke and...ping them out of the cell. Another gene called KE...ess. But lung cancer cells sabotage the expressio...
...t fly and a grant from the AICR ?the Association f...eading scientist in London identify potential targ...In one of the first studies of its kind, Dr Buzz B...te for Cancer Research (LICR) is using the tiny fr... which to identify genes that may impact on the sp...
... the University of Navarra, Borja Sáez Ochoa, has ...ple myeloma (MM), a type of bone marrow cancer, wh...er stages. , The dissertation of this biologist, p...l of Sciences of the University of Navarra, and in... Hospital of Schleswig-Holstein, en Kiel (Germany)...
...ix2 plays a critical role in the development of th...cells constantly available to produce the differen...f the organ, according to investigators at St. Jud... the process by which a progenitor (unspecialized)... in the body. , The kidney stem cells, called mese...
Other Biology News:Key to lung cancer chemo resistance revealed 2Using nature's most primitive anti-viral defense system to find new approaches to cancer research 2An advanced genetic diagnostic method for multiple myeloma 2Key gene controlling kidney development found 2
NAK/TBK1 (CT) Affinity Purified Polyclonal Antibody
...hthoyl-VF-CHO White lyophilized solid. PROTECT F...ble, reversible inhibitor of γ-secretase. Eq...ED 50 = 2.6 μM) and Aβ x-42 (ED 50 = 2....he Amyloid Precursor Protein Swedish mutants. Pur...
Mlu I from New England Biolabs
Corticoliberin
Biology Products: